- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Comparison
- Forums
- Visit our forums
- Jobs
- Visit our job site
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire New!
- Contact us
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
is a division of
- PR Newswire
- Senior Citizens
News of the day
Ageing Populations Face Crisis of Rising Blindness
4th October 2008 LONDON, October 4 /PRNewswire/ -- The world's populations are ageing rapidly, bringing greater risk of blindness and vision impairment to millions. Around the world, organisations of many kinds are joining forces to help protect the eyesight of older people, and to mark World Sight Day 2008 (WSD08). Worldwide, 45 million people are blind, the great majority of whom are over 50 years of age, but in over three-quarters of cases, especially those affecting older people, the sight loss results... moreProteoTech's Exebryl-1(R) Enters Human Clinical Trials for the Treatment of Alzheimer's Disease
7th August 2008 KIRKLAND, Washington, August 7 /PRNewswire/ -- ProteoTech Inc. (ProteoTech) today announced that it has completed regulatory Investigational New Drug (IND) requirements and has been cleared by the FDA to initiate its Phase 1 human clinical trial on Exebryl-1(R), a novel small molecule drug targeting toxic beta-amyloid protein accumulation for the treatment of Alzheimer's disease. ProteoTech initiated its Phase 1 human trial on July 29, 2008. At the 2008 International Conference on... moreSurvey Paints Bleak Picture of Funding for Continence Care Services
29th July 2008 LONDON, July 29 /PRNewswire/ -- A recent AHPMA survey among continence care professionals has painted a bleak picture on the current state of many continence services in the UK, largely due to lack of Government funding. The survey finds that continence care staff are striving for quality care within extremely limited resources. The survey received 148 responses, which show an unacceptably low level of funding in many Primary Care Trusts; morale being lower than five years ago in over half... more PR Newswire search
Most viewed
- The Institute of Psychoanalysis to Act as Expert Resource for the Media
- Longevinex(R) Found to be Superior to Green Tea Molecule in Independent Human Study
- ProteoTech's Exebryl-1(R) Enters Human Clinical Trials for the Treatment of Alzheimer's Disease
- Senetek Announces Plan for Promotion, Sales and Distribution of Pyratine-6(TM)
- Survey Paints Bleak Picture of Funding for Continence Care Services
More recent news
Senetek Announces Plan for Promotion, Sales and Distribution of Pyratine-6(TM)
1st July 2008 NAPA, California, July 1 /PRNewswire/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged
in the development of technologies that target the science of healthy aging,
today...
The Institute of Psychoanalysis to Act as Expert Resource for the Media
2nd April 2008 LONDON, April 2 /PRNewswire/ -- The Institute of Psychoanalysis is offering itself as a resource for
press and media, with a group of expert spokespeople available to comment on
current affairs,...
Longevinex(R) Found to be Superior to Green Tea Molecule in Independent Human Study
31st March 2008 SAN DIMAS, California, March 31 /PRNewswire/ -- While molecular biologists and news reporters present jaw-dropping
evidence that a red wine molecule called resveratrol may usher in the advent
of...
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us